Kyleena 19.5 MG systems
Ended Awarded
- Contract number
- SPE2DB25FPRQ7
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,577
Award facts
- Contract value 100% obligated
- $5,577.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a $5,577.21 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on September 26, 2025, for Kyleena 19.5 mg contraceptive systems. The delivery order is expected to be completed by October 20, 2025. This award was issued without a set-aside designation, allowing the company to compete on an unrestricted basis despite its small business status. The delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA, a single-award vehicle valued at $499,999,999 and valid through November 2026, which authorizes the agency to issue firm fixed-price orders for a comprehensive range of pharmaceutical products supporting military health facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its extensive portfolio of branded and generic prescription drugs, biologics, and medical consumables. The company's track record with DLA demonstrates consistent performance delivering diverse pharmaceutical products ranging from contraceptive devices to oncology treatments and specialty medications. The Kyleena delivery order represents the type of routine pharmaceutical resupply that the company executes regularly to support Department of Defense healthcare operations globally.
Quick answers
Who was awarded contract SPE2DB25FPRQ7?
SPE2DB25FPRQ7 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FPRQ7 worth?
The government has obligated $5,577 on SPE2DB25FPRQ7.
Is contract SPE2DB25FPRQ7 an order under another contract?
Yes. SPE2DB25FPRQ7 is a delivery order under SPE2DB20D9127, an indefinite delivery contract.
Was contract SPE2DB25FPRQ7 competed?
The extent of competition for SPE2DB25FPRQ7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award